• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Opinion
    • Global Health

    Opinion: The HPV vaccine is a cancer moonshot. Why then is uptake so low?

    Cervical cancer should be well on the way to elimination given an effective vaccine exists. But only 2 in 10 girls are getting the vaccine at recommended ages.

    By Anuradha Gupta // 11 January 2024

    When women talk about their ordeal with cervical cancer, I first hear gratitude that they survived. And then I hear frustration and fury that an almost entirely preventable cancer remains a continued and escalating threat. A woman is diagnosed with cervical cancer nearly every minute and dies every 90 seconds. By the time you read this article, someone somewhere will have lost a mother, wife, daughter, or sister to this vicious disease.

    Cervical cancer should be akin to smallpox and polio by now — maladies seen more in history books than in modern-day medical clinics. After all, we have an extremely effective vaccine against the human papillomavirus, or HPV — the virus that causes more than 95% of all cervical cancer cases. The vaccine has been shown to be safe time and again, having been administered 500 million times since regulators approved it nearly 20 years ago.

    But uptake of vaccination and screening is hampered by inequity, stigma, and lack of information. January is Cervical Cancer Awareness Month, and now is the time for action on cervical cancer elimination.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    Read more:

    ► The van bringing HPV testing to rural Kenya

    ► Opinion: We can, and must, eliminate cervical cancer

    ► Opinion: International community holds the key to ending cervical cancer 

    • Global Health
    • Social/Inclusive Development
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
    The views in this opinion piece do not necessarily reflect Devex's editorial views.

    About the author

    • Anuradha Gupta

      Anuradha Gupta

      Anuradha Gupta joined the Sabin Vaccine Institute in October 2022 as president of global immunization. A veteran public health leader, Anuradha has in her previous roles spearheaded a host of successful global initiatives to improve the health of women and children and harness the full power of vaccines. Her work has created a profound impact at a global scale, saving and improving millions of lives. Prior to Sabin, Anuradha spent several years at Gavi, The Vaccine Alliance, as its deputy CEO.

    Search for articles

    Related Stories

    Sexual and reproductive health rightsGavi cervical cancer campaign aims to reach African girls through sports

    Gavi cervical cancer campaign aims to reach African girls through sports

    Sponsored by The Pfizer FoundationSupporting community-driven solutions to address breast cancer

    Supporting community-driven solutions to address breast cancer

    Accelerating Action: Sponsored by World Child CancerOpinion: UHC must start somewhere — why not childhood cancer?

    Opinion: UHC must start somewhere — why not childhood cancer?

    Global HealthUS funding cuts risk spread of hepatitis

    US funding cuts risk spread of hepatitis

    Most Read

    • 1
      Opinion: Mobile credit, savings, and insurance can drive financial health
    • 2
      FCDO's top development contractors in 2024/25
    • 3
      How AI-powered citizen science can be a catalyst for the SDGs
    • 4
      Strengthening health systems by measuring what really matters
    • 5
      Opinion: India’s bold leadership in turning the tide for TB
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement